170634 ⎘
Assays involving biological materials from specific organisms or of a specific nature; Enzymes; Proenzymes; Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
Inhibitors of activin-like receptor kinases
#302Compositions for detecting mutant anaplastic lymphoma kinase in lung cancer
#303SCREENING METHODS USING FYN IN COMBINATION WITH TAU PROTEIN
#304Methods for inhibiting mesenchymal phenotype after epithelial-to-mesenchymal transition
#305High-Throughput Assay for Identifying Small Molecules that Modulate AMP-activated Protein Kinase (AMPK)
#306Methods for predicting and improving the survival of colorectal cancer patients
#307Assays for BTK inhibitors
#308Diagnostic method for pediatric acute-onset neuropsychiatric syndrome (PANS) and pediatric autoimmune neuropsychiatric disorder associated with streptococci infection (PANDAS)
#309Identification, selection and use of high curative potential T cell epitopes
#310Combination therapies for malaria
#311Antigen binding protein and its use as addressing product for the treatment of cancer
#312Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571
#313TREATMENT OF MTOR HYPERACTIVE RELATED DISEASES AND DISORDERS
#314METHODS FOR ASSAYING JAK2 ACTIVITY IN RED BLOOD CELLS AND USES THEREOF
#315Visualization of P-TEFb by Fluorescence Complementation
#316Inhibition of AXL Signaling in Anti-Metastatic Therapy
#317METHODS AND COMPOSITIONS FOR THE DIAGNOSIS OF ALZHEIMER'S DISEASE
#318METHODS FOR DIAGNOSIS, PROGNOSIS AND METHODS OF TREATMENT
#319KINASE ACTIVITY DETECTION METHODS
#320METHOD FOR PREDICTING THE RESPONSE TO HER2-DIRECTED THERAPY
#321Methods of using U2-OS cells to identify potential sweet taste modulators
#322METHODS, COMPOSITIONS AND KITS FOR PROMOTING MOTOR NEURON SURVIVAL AND TREATING AND DIAGNOSING NEURODEGENERATIVE DISORDERS
#323Homogenous thermal shift ligand binding assay
#324UREIDO-PYRAZOLE DERIVATIVES
#325Using phage epitopes to profile the immune response
#326SYSTEMS AND METHODS FOR FACILITATING DIAGNOSIS, PROGNOSIS AND TREATMENT OF CANCER BASED ON DETECTION OF HER3 ACTIVATION
#327Mutations in DSTYK cause dominant urinary tract malformations
#328Glycine, Mitochondrial One-Carbon Metabolism, and Cancer
#329Method of reducing blood glucose by administering RON agonists
#330Composition and method for preventing or treating a tauopathy
#331Use of antisecretory factors (AF) for optimizing cellular uptake
#332Systems And Methods For Early Detection Of Cervical Cancer By Multiplex Protein Biomarkers
#333METHODS FOR IDENTIFYING NEUROPROTECTIVE PKC ACTIVATORS
#334METHODS OF PREDICTING RESPONSIVENESS OF A CANCER TO AN AGENT AND METHODS OF DETERMINING A PROGNOSIS FOR A CANCER PATIENT
#335Artificial synthetic cDNA and method for detecting secondary glioblastoma
#336Non-Antagonistic EGFR-Binding Molecules and Immunoconjugates Thereof
#337FAM150A, FAM150B, AND FAM150 ANTAGONISTS AND USES THEREOF
#338Assay to determine LRRK2 activity in parkinson's disease
#339Method of Forming Fragment Ligated Inhibitors
#340Protein kinase inhibitors
#341METHOD AND APPARATUS OF AIDING DETECTION OF SURFACE ABNORMALITY IN THE OESOPHAGUS
#342USE OF PKC-ZETA AS A BREAST CANCER TUMORIGENIC BIOMARKER AS WELL AS A TARGET FOR TREATMENT OF BREAST CANCER
#343PERFLUORO-TERT-BUTYL HYDROXYPROLINE
#344Modular point-of-care devices, systems, and uses thereof
#345Modular point-of-care devices, systems, and uses thereof
#346HER3 protein SRM/MRM assay
#347Targeting phosphofructokinase and its glycosylation form for cancer
#348Methods of treating cholangiocarcinoma
#349METHODS OF MODULATING DLK STABILITY
#350Effective treatment of esophageal adenocarcinoma using triciribine and related compounds
#351Azaindole derivatives as multi kinase inhibitors
#352Method of identifying treatment responsive non-small cell lung cancer using anaplastic lymphoma kinase (ALK) as a marker
#353MEK Mutations Conferring Resistance to MEK Inhibitors
#354MUTANT AKT-SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING
#355Means and methods applying sFlt-1/PlGF or endoglin/PlGF ratio to rule out onset of preeclampsia within a certain time period
#356Inhibitors of atypical protein kinase C and their use in treating hedgehog pathway-dependent cancers
#357Methods of Treating Hematological Proliferative Disorders by Targeting EphA3 Expressed on Aberrant Vasculature in Bone Marrow
#358Monoclonal antibodies against c-Met
#359Method for diagnosing neurodegenerative diseases
#360Fragment ligated inhibitors selective for the polo box domain of PLK1
#361BIOMARKER PANEL FOR PREDICTION OF RECURRENT COLON CANCER
#362Combinations of a PI3K/AKT inhibitor compound with an HER3/EGFR inhibitor compound and use thereof in the treatment of a hyperproliferative disorder
#363IDENTIFICATION OF MODULATORS OF BINDING PROPERTIES OF ANTIBODIES REACTIVE WITH A MEMBER OF THE INSULIN RECEPTOR FAMILY
#364Compositions including triciribine and taxanes and methods of use thereof
#365Tumor cell-derived microvesicles
#366METHODS OF PROGNOSTICATING AND TREATING CANCER
#367METHOD FOR DETERMINING KINASE ACTIVITY
#368RET inhibitor
#369COMPANION DIAGNOSTICS FOR TEC FAMILY KINASE INHIBITOR THERAPY
#370NANOMATERIAL-INDUCED CYTOTOXICITY DETECTION COMPOSITION AND KIT, AND NANOMATERIAL-INDUCED CYTOTOXICITY DETECTION METHOD
#371LKB1 AS PREDICTIVE MARKER OF EVEROLIMUS EFFICACY IN BREAST CANCER
#372Method for measuring ATR inhibition mediated increases in DNA damage
#373Methods and compositions for treating alzheimer's disease
#374METHODS FOR DIAGNOSING, PROGNOSING, OR THERANOSING A CONDITION USING RARE CELLS
#375Assays and Cell-Based Tests Using a Receptor Na/K-ATPase/Src Complex and Uses Thereof
#376Combination treatment of cancer
#377METHOD FOR THE SELECTION AND PRODUCTION OF TAILOR-MADE, SELECTIVE AND MULTI-SPECIFIC THERAPEUTIC MOLECULES COMPRISING AT LEAST TWO DIFFERENT TARGETING ENTITIES AND USES THEREOF
#378Agents useful for treating obesity, diabetes and related disorders
#379Methods using Axl as a biomarker of epithelial-to-mesenchymal transition
#380METHOD FOR TREATING TAU PROTEIN-MEDIATED DEGENERATIVE NEURONAL DISEASE
#381Method of inhibiting constitutively active phosphorylated FLT3 kinase
#382Peptides derived from NCAPG2 and their use
#383FGFR2 FUSION GENE
#384Cell-Based Assays For Post-Translational Enzyme Activity
#385Histological markers for identifying non-small cell lung carcinoma patients for treatment with an anti-EGFR drug
#386Whole blood assay for measuring AMPK activation
#387Compounds and methods of use thereof for treating neurodegenerative disorders
#388CANCER PROGNOSTIC ASSAYS
#389PYRUVATE DEHYROGENASE KINASES AS THERAEUTIC TARGETS FOR CANCER AND ISCHEMIC DISEASES
#390Method And System For Detecting Lymphosarcoma in Cats Using Biomarkers
#391AMPK activator screening method, and AMPK activator
#392Method of inhibiting FLT3 kinase
#393Methods and compositions for identifying, diagnosing, and treating neuroblastoma
#394LIM kinasemodulating agents for neurofibromatoses therapy and methods for screening for same
#395MEANS AND METHODS FOR DIAGNOSTICS AND THERAPEUTICS OF DISEASES
#396Goodpasture Antigen Binding Protein Detection and Inhibition and its Use in Diabetes
#397COMPOSITIONS AND METHODS FOR TREATING CANCER USING INTERFERON AND MAPK PATHWAY INHIBITOR
#398Agents and methods for treating and preventing seborrheic keratosis
#399Cyclic peptides as protein targeting agents
#400Neurofibromatoses therapeutic agents and screening for same
#401Goodpasture Antigen Binding Protein and Its Detection
#402Substituted quinoxalines as B-raf kinase inhibitors
#403Composition and method for diagnosis and immunotherapy of lung cancer
#404Antigen binding protein and its use as addressing product for the treatment of cancer
#405Phosphorylation of histones and uses thereof
#406LKB1/STK11 DELETION IN MELANOMA AND RELATED METHODS
#407Methods for identifying protein-protein interactions
#408METHOD FOR DETECTING COMPOUND-BINDING PROTEIN
#409Methods for diagnosing and identifying modulators of membrane potentials in bipolar disorder and attention deficit hyperactivity disorder
#410DDR2 mutations as targetable features of melanoma or basal cell carcinoma
#411Methods and kits for diagnosing Sjögren's syndrome
#412Alzheimer's disease-specific alterations of the ERK1/ERK2 phosphorylation ratio-alzheimer's disease-specific molecular biomarkers (ADSMB)
#413Assay for detection of transient intracellular Ca
#414Signaling molecule involved in ultraviolet damage to skin
#415NLK as a marker for diagnosis of liver cancer and as a therapeutic agent thereof
#416BIOMARKERS FOR PI3K-DRIVEN CANCER
#417PREDICTIVE BIOMARKERS FOR PI3K/AKT KINASE PATHWAY INHIBITOR EFFICACY
#418Rho kinase inhibitors for treatment of mastocytosis and acute myeloid leukemia
#419ULK1 COMPOSITIONS, INHIBITORS, SCREENING AND METHODS OF USE
#420Methods of treating hematological proliferative disorders by targeting EphA3 expressed on aberrant vasculature in bone marrow
#421BRAF mutations conferring resistance to BRAF inhibitors
#422Methods for diagnosis, prognosis and methods of treatment
#423DETECTION OF UNHEALTHY BONE MARROW-DERIVED CELL FOR DISEASE PREDISPOSITIONS
#424Biomarker for identifying subgroup of early-stage lung adenocarcinoma patients
#425Inhibitors of atypical protein kinase C and their use in treating hedgehog pathway-dependent cancers
#426METHOD FOR DIAGNOSIS NON-SMALL-CELL-LUNG-CARCINOMA (NSCLC) AND CLASSIFICATION OF ITS SUBTYPES WITH DIFFERENT COMBINATIONS OF 6 PROTEIN BIOMARKERS
#427Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571
#428Methods for treating and diagnosing disease
#429ROS Kinase in Lung Cancer
#430Fragment ligated inhibitors selective for the polo box domain of PLK1
#431Effective treatment of esophogeal adenocarcinoma using triciribine and related compounds
#432Method Of Diagnosis Or Prognosis Of A Neoplasm Comprising Determining The Level Of Expression Of A Protein In Stromal Cells Adjacent To The Neoplasm
#433ANTI-KIT ANTIBODIES AND USES THEREOF
#434Compositions and Methods for Modulation of Bone Density and Biomineralization
#435Whole blood assay for measuring AMPK activation
#436INCREASING LIFESPAN BY MODULATING CRTC EXPRESSION OR LOCALIZATION, AND METHODS OF SCREENING FOR MODULATORS OF SAME
#437USE OF PKC-ZETA AS A BREAST CANCER TUMORIGENIC BIOMARKER AS WELL AS A TARGET FOR TREATMENT OF BREAST CANCER
#438METHODS USING AXL AS A BIOMARKER OF EPITHELIAL-TO-MESENCHYMAL TRANSITION
#439NON-SURGICAL APPROACH TO PREVENT AND CORRECT CRANIOFACIAL MALFORMATIONS DURING DEVELOPMENT
#440Modular point-of-care devices, systems, and uses thereof
#441Composition and method for treating a tauopathy
#442RAF gene fusions
#443USE OF PKC ISOZYMES FOR DIAGNOSIS AND TREATMENT OF NEUROBLASTOMA
#444METHODS FOR THE DIAGNOSIS OR PROGNOSIS OF COLORECTAL CANCER
#445Co-targeting of aurora A kinase and LIM kinase 1 for cancer therapy
#446Methods and means for treatment of osteoarthritis
#447MUTATIONS IN THE BCR-ABL TYROSINE KINASE ASSOCIATED WITH RESISTANCE TO STI-571
#448MEK mutations conferring resistance to MEK inhibitors
#449HIGH RESOLUTION COMPLEX STRUCTURE AND ALLOSTERIC EFFECTS OF LOW MOLECULAR WEIGHT ACTIVATORS ON THE PROTEIN KINASE PDK1
#450Methods for identifying modulators of LRRK2
#451USING PHAGE EPITOPES TO PROFILE THE IMMUNE RESPONSE
#452Gene defects and mutant ALK kinase in human solid tumors
#453Goodpasture Antigen Binding Protein and its Detection
#454Methods and compositions for treating alzheimer's disease
#455PAK1 agonists and methods of use
#456Method and system for determination of molecular interaction parameters
#457Method for predicting the response to HER2-directed therapy
#458Methods for modulating IKKα activity
#459Biomarkers of tumor pharmacodynamic response
#460GENE SIGNATURES
#461PD-1, A Receptor for B7-4, and Uses Therefor
#462ANTI-ErbB2 ANTIBODIES
#463Gene defects and mutant ALK kinase in human solid tumors
#464Methods and Compositions for Identifying, Diagnosing, and Treating Neuroblastoma
#465Method for determining the sensitivity of patients suffering from a cancer disease to biological therapy
#466COMPOSITIONS INCLUDING TRICIRIBINE AND EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITOR COMPOUNDS OR SALTS THEREOF AND METHODS OF USE THEREOF
#467Marks as modifiers of the p53 pathway and methods of use
#468Gene defects and mutant ALK kinase in human solid tumors
#469DISCOVERY AND VALIDATION OF CANCER BIOMARKERS USING A PROTEIN ANALYSIS METHODOLOGY TO ANALYZE SPECIMENS
#470TUMOR CELL-DERIVED MICROVESICLES
#471MUTATIONS IN THE BCR-ABL TYROSINE KINASE ASSOCIATED WITH RESISTANCE TO STI-571
#472IL-18 and Protein Kinase R Inhibition for the Treatment of COPD
#473USE OF BIOMARKERS FOR THE DIAGNOSIS AND PROGNOSIS OF LUNG CANCER
#474Assay for detection of transient intracellular CA
#475DEVICES AND METHODS FOR DIAGNOSING, PROGNOSING, OR THERANOSING A CONDITION BY ENRICHING RARE CELLS
#476METHODS FOR DIAGNOSING, PROGNOSING, OR THERANOSING A CONDITION USING RARE CELLS
#477SCDs as modifiers of the p53 pathway and methods of use
#478PREVENTIVE OR REMEDY FOR ER-NEGATIVE AND HER2-NEGATIVE BREAST CANCER AND METHOD OF SCREENING THE SAME
#479Detection of Unhealthy Cell and Uses Thereof
#480Methods and Compositions for Inhibiting GSK-3 In Glial Cell Related Disorders
#481Effective treatment of esophogeal adenocarcinoma using triciribine and related compounds
#482Mutations in the Bcr-Abl tyrosine kinase associated with resistance to ST1-571
#483Anti-HIMF antibodies to treat lung diseases
#484Gene/protein marker for prediction or diagnosis of pharmacological efficacy of aurora a inhibitor
#485Information Transmittal And Notification System
#486USING BUDDING YEAST TO SCREEN FOR INHIBITORS OF AURORA KINASES
#487COMPOSITIONS INCLUDING TRICIRIBINE AND TAXANES AND METHODS OF USE THEREOF
#488β-TrCP1, β-TrCP2 and RSK1 or RSK2 inhibitors and methods for sensitizing target cells to apoptosis
#489Distinguishing cells in a sample by inactivating extracellular enzyme before releasing intracellular enzyme
#490MASS SPECTROMETRY METHODS FOR MULTIPLEXED QUANTIFICATION OF PROTEIN KINASES AND PHOSPHATASES
#491Method for supporting a diagnosis of an effect of a treatment by using anthracycline anticancer drugs and a device for supporting a diagnosis for an effect of a treatment by using anthracycline anticancer drugs
#492Pyruvate dehydrogenase kinases as therapeutic targets for cancer and ischemic diseases
#493NOVEL HOMOLOGY MODEL OF THE GLYCOGEN SYNTHASE KINASE 3 ALPHA AND ITS USES THEREOF
#494Gene defects and mutant ALK kinase in human solid tumors
#495Mutations in the BCR-ABL tyrosine kinase associated with resistance to STI-571
#496THERAPY FOR NEUROLOGICAL DISEASES
#497Methods for diagnosis prognosis and methods of treatment
#498Methods for modulating checkpoint activation through TopBP1
#499Modular point-of-care devices, systems, and uses thereof
#500Serine and threoninephosphorylation sites
#501Alzheimer's Disease-Specific Alterations of the Erk1/Erk2 Phosphorylation Ratio-Alzheimer's Disease-Specific Molecular Biomarkers (Adsmb)
#502Use of calmodulin kinase II inhibitors to treat myocardial dysfunction in structural heart disease
#503Methods For Determining Presence of Cancer by Analyzing the Expression of Cdk9 and/or Cyclin T1 in Lymphoid Tissue
#504Methods for screening for compounds that modulate PD-1 signaling
#505Method and system for determination of molecular interaction parameters
#506APPARATUS FOR SUPPORTING DIAGNOSIS OF CANCER
#507MARKs as Modifiers of the p53 Pathway and Methods of Use
#508Methods for modulating checkpoint activation through TopBP1
#509Anti-ErbB2 antibodies
#510Method of screening for inhibitors of tau protein phosphororylation by tyrosine kinase c-Abl
#511SCDs As Modifiers of the p53 Pathway and Methods of Use
#512Assays and kits for detecting protein binding
#513Method for treating an immune disorder by decreasing NIK-SIVA complex formation
#514PYRUVATE-KINASE AS A NOVEL TARGET MOLECULE
#515Methods and compositions for altering mucus secretion
#516Metal ion mediated fluorescence superquenching assays, kits and reagents
#517DETECTION OF PHOSPHORYLATED eIF2-alpha AS A DIAGNOSTIC TEST FOR EFFICACY AND SENSITIVITY OF TRANSLATION INITIATION INHIBITORS IN THE TREATMENT OF CANCER AND OTHER PROLIFERATIVE DISEASES
#518Methods for modulating IKKα activity
#519Remedy for cardiac failure containing ask1 inhibitor as active ingredient and method for screening the same
#520Compositions and methods for identifying modulators of transducisomes, a new class of therapeutic targets
#521Method for judging feature of malignant tumor
#522Pknb kinase and pstp phosphatase and methods of identifying inhibitory substances
#523Tissue diagnostics for breast cancer
#524Method for detecting protein
#525Tissue characteristic determination apparatus
#526Reagent kit for determining characteristic of tissue
#527Diagnostic method for brain damage-related disorders
#528Predictive Methods For Cancer Chemotherapy
#529Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571
#530LIMKs as modifiers of p53 pathway and methods of use
#531PknB kinase and pstP phosphatase and methods of identifying inhibitory substances
#532CDK2/cyclin A crystals and uses thereof
#533Use of tyrosine kinase inhibitors for treating substance use disorders
#534Chds as modifiers of the p53 pathway and methods of use
#535Diagnostic markers and pharmacological targets in heart failure and related reagents and methods of use thereof
#536Dgks as modifiers of the p53 pathwha and methods of use
#537Methods based on hormone dependency of primary cancer cells
#538Methods for modulating IKKα activity
#539Method and system for determination of molecular interaction parameters
#540Assays and kits for detecting protein binding
#541Anti-ROR1 antibody and use thereof